Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |